Catalyst Wire Dossier Catalyst Wire Dossier

AL-794

· Alios Biopharma Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AL-794, covering 2017-06-22 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healthy Volunteers [Phase 1]

See pricing